JPRN-UMIN000028116招募中2 期
Phase II study of chemoradiotherapy combined with gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancer - NUPAT 05
agoya University Pancreatic Tumor Bord0 个研究点目标入组 25 人开始时间: 2017年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Distant metastasis 2) Allergy to gemcitabine or nab-paclitaxel 3) Invasion to digestive tract 4) Severe allergy to drags 5) Infection 6) Severe cardiovascular disease 7) Severe basal disease 8) Double cancer 9) Peripheral sensory neuropathy or myelopathy 10) ascites or pleural effusion 11) Active digestive tract bleeding 12) Severe diarrhea 13) Fibroid lung 14) History of radiotherapy for abdomen 15) Uncontrolled cancer pain 16) Lung would be included within radiation field 17) Uncontrolled severe mental disease 18) Pregnant 19) Not obtained consent to this trail 20) Not appropriate for the study at the physician's assessment.
研究者
相似试验
已完成
2 期
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)terine cervical carcinomaJPRN-UMIN000002937Japanese Cancer Clinical Research Organization(JACCRO)70
已完成
2 期
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40
尚未招募
1 期
Phase I study of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear.eoplasm of the external auditory canal and middle earJPRN-UMIN000013304Kobe University Hospital12
已完成
2 期
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophaguscervical esophageal cancerJPRN-UMIN000001439ational Cancer Center Hospital32
已完成
2 期
A phase II study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancerStage III non-small cell lung cancerJPRN-UMIN000010428West Japan Oncology Group44